Biostate AI
Houston, US · Founded 2023 · Delaware corporation · 4 known investors
Biostate AI is a biotech company that develops AI-driven solutions for the life sciences and medical research sectors. The company operates multiple international subsidiaries and partnerships focused on advancing genomics and health diagnostics.
Founders & leadership
TK
Timothy KassisCo-Founder & Head of AI
EM
Eva MiaoExecutive Officer
AG
Ashwin GopinathExecutive Officer, Director
DZ
David ZhangExecutive Officer, Director
DY
David Y. ZhangExecutive Officer, Director
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$4.2MraisedMay 2025 · 7 investors · BiotechnologyRule 506(b)
▶$4.2MraisedMay 2025 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eva MiaoExecutive Officer
- Ashwin GopinathExecutive Officer, Director
- David ZhangExecutive Officer, Director
- Offering amount
- $13M
- Amount sold
- $4.2M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$1MraisedAug 2023 · 1 investors · OtherRule 506(b)
▶$1MraisedAug 2023 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ashwin GopinathExecutive Officer, Director
- Eva MiaoExecutive Officer
- David Y. ZhangExecutive Officer, Director
- Offering amount
- $14M
- Amount sold
- $1M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Deeptech startup Biostate AI raises $12 million in led by Accel, othersindianstartupnews.com · 2025
- Biostate AI Raises $12M Series A to Train the ChatGPT of Molecular Medicine - Unite.AIunite.ai · 2025
- Medpathtrial.medpath.com · 2025
- Biostate AI raises $12M for RNA sequencing data productaxios.com · 2025
- Biostate AI Raises $12M in Series A Funding | GenomeWebgenomeweb.com · 2025
- Biostate AI closes $12M to bring the Netflix model to molecular diagnosticsglobenewswire.com · 2025